CbdMD Net Worth
CbdMD Net Worth Breakdown | YCBD |
CbdMD Net Worth Analysis
CbdMD's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including CbdMD's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of CbdMD's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform CbdMD's net worth analysis. One common approach is to calculate CbdMD's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares CbdMD's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing CbdMD's net worth. This approach calculates the present value of CbdMD's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of CbdMD's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate CbdMD's net worth. This involves comparing CbdMD's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into CbdMD's net worth relative to its peers.
Enterprise Value |
|
To determine if CbdMD is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CbdMD's net worth research are outlined below:
| cbdMD Inc generated a negative expected return over the last 90 days | |
| cbdMD Inc has some characteristics of a very speculative penny stock | |
| cbdMD Inc has high historical volatility and very poor performance | |
| cbdMD Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 24.16 M. Net Loss for the year was (22.94 M) with profit before overhead, payroll, taxes, and interest of 22.34 M. | |
| cbdMD Inc currently holds about 10.55 M in cash with (4.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17. | |
| cbdMD Inc has a poor financial position based on the latest SEC disclosures | |
| Roughly 19.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: cbdMD Launches THC Seltzers in 4B Market Push with Fast-Acting Technology YCBD Stock News - StockTitan |
CbdMD uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in cbdMD Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CbdMD's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Follow CbdMD's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.73 M.Market Cap |
|
Project CbdMD's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.03) | (2.13) | |
| Return On Capital Employed | (0.92) | (0.88) | |
| Return On Assets | (1.63) | (1.71) | |
| Return On Equity | (2.29) | (2.40) |
When accessing CbdMD's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures CbdMD's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CbdMD's profitability and make more informed investment decisions.
Please note, the presentation of CbdMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CbdMD's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CbdMD's management manipulating its earnings.
Evaluate CbdMD's management efficiency
cbdMD Inc has return on total asset (ROA) of (0.1571) % which means that it has lost $0.1571 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3507) %, meaning that it created substantial loss on money invested by shareholders. CbdMD's management efficiency ratios could be used to measure how well CbdMD manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -2.13. The current year's Return On Capital Employed is expected to grow to -0.88. At present, CbdMD's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 167.5 K, whereas Non Current Assets Total are forecasted to decline to about 8.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.02 | 3.82 | |
| Tangible Book Value Per Share | 2.59 | 2.72 | |
| Enterprise Value Over EBITDA | (0.48) | (0.50) | |
| Price Book Value Ratio | 0.27 | 0.25 | |
| Enterprise Value Multiple | (0.48) | (0.50) | |
| Price Fair Value | 0.27 | 0.25 | |
| Enterprise Value | 4.6 M | 4.3 M |
CbdMD's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Enterprise Value Revenue 0.1672 | Revenue 20.6 M | Quarterly Revenue Growth (0.15) | Revenue Per Share 7.06 | Return On Equity (1.35) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CbdMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on CbdMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CbdMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kennedy Thomas Ronan over a month ago Acquisition by Kennedy Thomas Ronan of 16667 shares of CbdMD subject to Rule 16b-3 | ||
Kennedy Thomas Ronan over two months ago Acquisition by Kennedy Thomas Ronan of 1000 shares of CbdMD at 270.0 subject to Rule 16b-3 | ||
Kennedy Thomas Ronan over two months ago Acquisition by Kennedy Thomas Ronan of 38465 shares of CbdMD at 270.0 subject to Rule 16b-3 | ||
Raines William F Iii over three months ago Acquisition by Raines William F Iii of 75000 shares of CbdMD subject to Rule 16b-3 | ||
Bradley Whitford over six months ago Disposition of tradable shares by Bradley Whitford of CbdMD subject to Rule 16b-3 | ||
Sellers Bakari T. over six months ago Acquisition by Sellers Bakari T. of 2000 shares of CbdMD at 0.93 subject to Rule 16b-3 | ||
Wiesehan John J Iii over six months ago Acquisition by Wiesehan John J Iii of 161550 shares of CbdMD at 2000000.0 subject to Rule 16b-3 | ||
Sellers Bakari T over a year ago Acquisition by Sellers Bakari T of 5000 shares of CbdMD subject to Rule 16b-3 |
CbdMD Earnings per Share Projection vs Actual
CbdMD Corporate Management
| Zeb Booker | Chief Officer | Profile | |
| Raymond Coffman | CoFounder Chairman | Profile | |
| Kevin MacDermott | President | Profile | |
| John Weston | Director Relations | Profile | |
| Shannon Charles | Chief Officer | Profile | |
| Francisco Mangual | Senior Sales | Profile |
Already Invested in cbdMD Inc?
The danger of trading cbdMD Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CbdMD is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CbdMD. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile cbdMD Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.90) | Revenue Per Share 7.06 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) | Return On Equity (1.35) |
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.